Kyverna Therapeutics, Inc.(KYTX)
$5.03-0.09 (-1.76%)
KYTX
Kyverna Therapeutics, Inc. financials statements
$5.03
At close:-0.09 (-1.76%)
Want to see KYTX full AI Analyst Report?
Kyverna Therapeutics, Inc. (KYTX) Income Statement
1,057 Followers
Kyverna Therapeutics, Inc. Income Statement
Last quarter (Q3 2026), Kyverna Therapeutics, Inc.'s total revenue was $0.00. In Q3, Kyverna Therapeutics, Inc.'s net income was $-41.94M. See Kyverna Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 7.03M | $ 5.66M | |
| $ 0.00 | $ -2.13M | $ -1.71M | $ 7.03M | $ 5.66M | |
| $ 169.83M | $ 140.47M | $ 60.70M | $ 36.41M | $ 32.00M | |
| Depreciation and Amortization | $ 1.80M | $ 2.13M | $ 1.71M | $ 1.05M | $ 586.00K |
| $ -159.02M | $ -125.20M | $ -58.47M | $ -27.78M | $ -25.76M | |
| $ -169.83M | $ -142.60M | $ -62.41M | $ -29.38M | $ -26.35M | |
| $ 8.52M | $ 15.13M | $ 2.04M | $ 491.00K | $ -4.00K | |
| $ -161.31M | $ -127.48M | $ -60.37M | $ -28.89M | $ -26.35M | |
| $ -161.31M | $ -127.48M | $ -60.37M | $ -28.89M | $ -26.35M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.64 | $ -3.33 | $ -1.40 | $ -0.67 | $ -0.61 |
| Diluted EPS | $ -3.64 | $ -3.33 | $ -1.40 | $ -0.67 | $ -0.61 |
| Weighted Average Shares Outstanding | 44.26M | 38.33M | 43.12M | 43.12M | 43.12M |
| Weighted Average Shares Outstanding (Diluted) | 44.26M | 38.33M | 43.12M | 43.12M | 43.12M |
Currency in USD
